Chemical Structure (Arikayce 01)
Arikayce Suspension
Product Images NDC 71558-590
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Arikayce (NDC 71558-590). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Insmed Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Arikayce 02)
This appears to be a chart showing the percentage of subjects achieving "culture conversion" in a clinical trial, for two different drug regimens, over a period of five months. The first drug regimen (V-230) achieved a cumulative proportion of 29% of subjects achieving culture conversion by the end of the first month, while the second drug regimen (V-113) achieved a cumulative proportion of 27.2% by the end of the same period. The chart then shows the cumulative proportion of converters over the following four months.*
Figure (Arikayce 03)
Figure (Arikayce 04)
Figure (Arikayce 05)
Figure (Arikayce 06)
Figure (Arikayce 07)
Figure (Arikayce 08)
Figure (Arikayce 09)
Figure (Arikayce 10)
Figure (Arikayce 11)
Figure (Arikayce 12)
Figure (Arikayce 13)
Figure (Arikayce 14)
Figure (Arikayce 15)
Arikayce 15a
Figure (Arikayce 16)
Figure (Arikayce 17)
Figure (Arikayce 18)
Figure (Arikayce 19)
Figure (Arikayce 20)
Figure (Arikayce 21)
Figure (Arikayce 22)
Figure (Arikayce 23)
Figure (Arikayce 24)
Figure (Arikayce 25)
Figure (Arikayce 26)
Principal Display Panel (8.4 mL Vial Carton)
ARIKAYCE is a medication designed for oral inhalation only. It contains 28 sterile unit-dose vials, each containing amikacin 590mg/8.4mL (equivalent to amikacin sulfate 623mg/8.4mL). The medication is for a limited population only. Patients who want to use this medication are advised to store it refrigerated until the expiration date on the vial. Once expired, any unused medicine should be discarded. The medication can also be stored at room temperature up to 4 weeks. ARIKAYCE should be used with the Lamira Nebulizer Handset and Lamira Asrosol Heads provided. If interested, the full prescribing information for ARIKAYCE can be accessed. The product is manufactured for Insmed Incorporated, located in Bridgewater, NJ.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
